Blood | American Society of Hematology

Skip Nav Destination

Current Issue

Volume 143,

Issue 16,

April 18 2024

View This Issue

Issue Highlights

The β-catenin/Hoxa9/Prmt1 axis regulates HSC functions
SLE risk in children with chronic immune cytopenias
CME article: ibrutinib for first- line CLL
CPX-351, the gut microbiota, and mucosal integrity
Leukocytosis and thrombotic events in PV
Optimizing antimyeloma immunity for ASCT
Special Report: how to manage toxicity of CD3×CD20 bispecific antibody therapy

Latest in Blood

Free Articles

Nonleukemic T/B mixed phenotype acute leukemia with PHF6 and NOTCH1 mutations

Oscar Silva; Allison Shaw

https://doi.org/10.1182/blood.2021012538

View All Free Articles

Plenary Papers

Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation

Marios Dimitriou; Teresa Mortera-Blanco; Magnus Tobiasson; Stefania Mazzi; Madeleine Lehander; Kari Högstrand; Mohsen Karimi; Gunilla Walldin; Monika Jansson; Sofie Vonlanthen; Per Ljungman; Saskia Langemeijer; Tetsuichi Yoshizato; Eva Hellström-Lindberg; Petter S. Woll; Sten Eirik W. Jacobsen

https://doi.org/10.1182/blood.2023022851

View All Plenary Papers

First Edition

Primary Large B-cell Lymphomas of Immune-Privileged Sites

Mark Roschewski; James D. Phelan; Elaine S Jaffe

https://doi.org/10.1182/blood.2023020911

View All First Edition Articles

Clinical Trials and Observations

Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL

Aaron T. Gerds; Ruben Mesa; John M. Burke; Michael R. Grunwald; Brady L. Stein; Peg Squier; Jingbo Yu; J. E. Hamer-Maansson; Stephen T. Oh

https://doi.org/10.1182/blood.2023020232

View All Clinical Trials and Observations

Blood 2022 Impact Factor: 20.3

ASH Statement in Support of the Value of Scholarly Publishers

Acknowledgement of Reviewers

ASH Commitment to Diversity, Equity, and Inclusion in Health Care

Issue Highlights

Featured Content

Gut microbiota exploitation by CPX-351 in AML; optimizing anti-myeloma immunity for ASCT; which pediatric ITP patients will develop lupus?

CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis

Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation

Antinuclear antibody–associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus

Hematopoietic stem cell quiescence and DNA replication dynamics maintained by the resilient β-catenin/ Hoxa9/Prmt1 axis

Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL

ASH Publications

American Society of Hematology

Issue Highlights

Featured Content

Gut microbiota exploitation by CPX-351 in AML; optimizing anti-myeloma immunity for ASCT; which pediatric ITP patients will develop lupus?

CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis

Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation

Antinuclear antibody–associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus

Hematopoietic stem cell quiescence and DNA replication dynamics maintained by the resilient β-catenin/ Hoxa9/Prmt1 axis

Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only